http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7429608-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0597f9c318d2aeca86db94711c516383 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-30 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-30 |
filingDate | 2006-01-20^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2008-09-30^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63062e553083752123d0970b19967128 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8da5058d223baa753db41e463fe37a93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a4c2f6917df98cddc9e4986868360ad |
publicationDate | 2008-09-30^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-7429608-B2 |
titleOfInvention | Benzo[d]imidazol analogs as vanilloid receptor ligands and their use in treatments |
abstract | Substituted benzimidazoles and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10287284-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8759535-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10463652-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11649230-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10898475-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011201604-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10570126-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10172840-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11130753-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10030011-B2 |
priorityDate | 2005-01-20^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 995 of 995.